Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Byron Caughey

Showing results (161-170 of 185) with videos related to

Pageof 19
Sort By:
Pathogens (Basel, Switzerland)|February 23, 2024
Chronic Wasting Disease: State of the ScienceJason C Bartz, Rebeca Benavente, Byron Caughey, et al.
Plos One|January 9, 2014
Anti-prion activity of a panel of aromatic chemical compounds: in vitro and in silico approachesNatalia C Ferreira, Icaro A Marques, Wesley A Conceição, et al.
Acta Neuropathologica|November 22, 2019
Correction to: 4-Repeat tau seeds and templating subtypes as brain and CSF biomarkers of frontotemporal lobar degenerationEri Saijo, Michael A Metrick, Shunsuke Koga, et al.
Annals of Neurology|November 29, 2016
Diagnostic and prognostic value of human prion detection in cerebrospinal fluidAaron Foutz, Brian S Appleby, Clive Hamlin, et al.
Acta Neuropathologica|October 17, 2019
4-Repeat tau seeds and templating subtypes as brain and CSF biomarkers of frontotemporal lobar degenerationEri Saijo, Michael A Metrick, Shunsuke Koga, et al.
The Lancet. Neurology|February 20, 2021
Biomarkers and diagnostic guidelines for sporadic Creutzfeldt-Jakob diseasePeter Hermann, Brian Appleby, Jean-Philippe Brandel, et al.
Acta Neuropathologica Communications|June 1, 2023
Case report of a patient with unclassified tauopathy with molecular and neuropathological features of both progressive supranuclear palsy and corticobasal degenerationShunsuke Koga, Michael A Metrick, Lawrence I Golbe, et al.
JAMA Neurology|September 28, 2020
Skin α-Synuclein Aggregation Seeding Activity as a Novel Biomarker for Parkinson DiseaseZerui Wang, Katelyn Becker, Vincenzo Donadio, et al.
Medrxiv : the Preprint Server for Health Sciences|April 3, 2026
Brain-Only Versus GI-Only Synucleinopathy: A Comprehensive Autopsy Study With Both IHC and SAAChristina D Orru, Thomas G Beach, Charles H Adler, et al.
Acta Neuropathologica Communications|November 7, 2021
High diagnostic performance of independent alpha-synuclein seed amplification assays for detection of early Parkinson's diseaseMarco J Russo, Christina D Orru, Luis Concha-Marambio, et al.
Pageof 19

Showing results (161-170 of 185) with videos related to

Sort By:
Pageof 19
Pathogens (Basel, Switzerland)|February 23, 2024
Chronic Wasting Disease: State of the ScienceJason C Bartz, Rebeca Benavente, Byron Caughey, et al.
Plos One|January 9, 2014
Anti-prion activity of a panel of aromatic chemical compounds: in vitro and in silico approachesNatalia C Ferreira, Icaro A Marques, Wesley A Conceição, et al.
Acta Neuropathologica|November 22, 2019
Correction to: 4-Repeat tau seeds and templating subtypes as brain and CSF biomarkers of frontotemporal lobar degenerationEri Saijo, Michael A Metrick, Shunsuke Koga, et al.
Annals of Neurology|November 29, 2016
Diagnostic and prognostic value of human prion detection in cerebrospinal fluidAaron Foutz, Brian S Appleby, Clive Hamlin, et al.
Acta Neuropathologica|October 17, 2019
4-Repeat tau seeds and templating subtypes as brain and CSF biomarkers of frontotemporal lobar degenerationEri Saijo, Michael A Metrick, Shunsuke Koga, et al.
The Lancet. Neurology|February 20, 2021
Biomarkers and diagnostic guidelines for sporadic Creutzfeldt-Jakob diseasePeter Hermann, Brian Appleby, Jean-Philippe Brandel, et al.
Acta Neuropathologica Communications|June 1, 2023
Case report of a patient with unclassified tauopathy with molecular and neuropathological features of both progressive supranuclear palsy and corticobasal degenerationShunsuke Koga, Michael A Metrick, Lawrence I Golbe, et al.
JAMA Neurology|September 28, 2020
Skin α-Synuclein Aggregation Seeding Activity as a Novel Biomarker for Parkinson DiseaseZerui Wang, Katelyn Becker, Vincenzo Donadio, et al.
Medrxiv : the Preprint Server for Health Sciences|April 3, 2026
Brain-Only Versus GI-Only Synucleinopathy: A Comprehensive Autopsy Study With Both IHC and SAAChristina D Orru, Thomas G Beach, Charles H Adler, et al.
Acta Neuropathologica Communications|November 7, 2021
High diagnostic performance of independent alpha-synuclein seed amplification assays for detection of early Parkinson's diseaseMarco J Russo, Christina D Orru, Luis Concha-Marambio, et al.
Pageof 19